Related Experiment Video
Updated: Jun 6, 2025
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
All-in-one multiple extracellular vesicle miRNA detection on a miniaturized digital microfluidic workstation
Zhaoduo Tong1, Xin Xu2, Chuanjie Shen1
1State Key Laboratory of Transducer Technology, Shanghai Institute of Microsystem and Information Technology, Chinese Academy of Sciences, Shanghai, 200050, China; Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, 100049, China.
A new digital microfluidic workstation enables all-in-one detection of extracellular vesicle microRNAs (EV-miRNAs) for early cancer diagnosis. This automated system simplifies complex procedures, offering a promising tool for point-of-care diagnostics.
Area of Science:
- Biomarkers
- Microfluidics
- Molecular Diagnostics
Background:
- Extracellular vesicles (EVs) and their microRNAs (EV-miRNAs) show potential as circulating biomarkers for early cancer detection, including non-small cell lung cancer (NSCLC).
- Current RNA detection methods like reverse transcription - quantitative polymerase chain reaction (RT-qPCR) are hindered by laborious purification and multi-step processes for EV-miRNAs.
Purpose of the Study:
- To develop and demonstrate a miniaturized digital microfluidic (DMF) workstation for integrated, automated EV-miRNA detection.
- To overcome the limitations of traditional RT-qPCR for EV-miRNA analysis, enabling faster and simpler diagnostics.
Main Methods:
- Development of an all-in-one DMF workstation integrating EV-miRNA isolation and on-chip real-time RT-qPCR.
- Implementation of a one-step stem-looped RT-qPCR protocol for enhanced miRNA sensitivity and specificity.
- Demonstration using 20 μL plasma samples for detecting NSCLC-related EV-miRNAs.
Main Results:
- The DMF workstation achieved comparable detection sensitivity to in-vitro RT-qPCR (limit of detection = 2 copies/μL).
- The system provides automated, miniaturized, and facile EV-miRNA detection.
- Successful detection of NSCLC-related EV-miRNAs in plasma samples was achieved.
Conclusions:
- The proposed DMF workstation offers an automated and efficient solution for EV-miRNA detection.
- This technology has significant potential for point-of-care diagnosis of various diseases, including cancers.
- Methodological improvements enhance the sensitivity, specificity, and cost-effectiveness of EV-miRNA analysis.
